Epidemiology and Susceptibility Patterns of Hospital-Acquired Conjunctivitis in a Neonatal Intensive Care Unit
Objectives: The aims of this study were to determine the prevalence of pathogens causing bacterial hospital-acquired conjunctivitis (HAC) and to provide information about antibiotic susceptibility patterns among inpatient infants.
Methods: Infants with gram-negative (Group 1) or -positive (Group 2) bacterial conjunctivitis were included. Of 365 patients, 98 tested positive for bacteria; all data were collected retrospectively. Isolated pathogens and antibiotic susceptibility patterns were also obtained from the patient records.
Results: The most common pathogens were gram-negative bacteria, found in Group 1 (n=80, 82%). Group 2 included 18 (18%) infants with gram-positive conjunctivitis. There were no significant differences in demographics or clinical characteristics between the two groups. Ten neonates in Group 1 (12.5%) and two neonates in Group 2 (11.1%) had concomitant sepsis (p=0.60). In gram-positive conjunctivitis cases, Staphylococcus aureus (50%) was the predominant pathogen. In gram-negative conjunctivitis cases, Pseudomonas species (46.2%) was the most common pathogen, followed by Klebsiella species (27.5%) and Escherichia coli (12.5%). In gram-negative bacteria, the antibiotic resistance rates to gentamicin, netilmicin, and second- and third-generation fluoroquinolones were 48.1%, 14.3%, and 13% and 8.6%, respectively. We did not observe any unresponsive or complicated conjunctivitis cases.
Conclusion: Surveillance is essential in determining the rate of HAC and identifying the factors associated with the infection, and it is important to plan and evaluate prevention strategies.
1.Kawagoe JY, Segre CA, Pereira CR, Cardoso MF, Silva CV, Fukushima JT. Risk factors for nosocomial infections in critically ill newborns: a 5-year prospective cohort study. Am J Infect Control 2001;29:109–14. [CrossRef]
2. Teoh DL, Reynolds S. Diagnosis and management of pediatric conjunctivitis. Pediatr Emerg Care 2003;19:48–55. [CrossRef]
3. Wagner RS, Aquino M. Pediatric ocular inflammation. Immunol Allergy Clin North Am 2008;28:169–88. [CrossRef]
4. Couto RC, Carvalho EA, Pedrosa TM, Pedroso ER, Neto MC, Biscione FM. A 10-year prospective surveillance of nosocomial infections in neonatal intensive care units. Am J Infect Control 2007;35:183–9. [CrossRef]
5. Stover BH, Shulman ST, Bratcher DF, Brady MT, Levine GL, Jarvis WR; Pediatric Prevention Network. Nosocomial infection rates in US children's hospitals' neonatal and pediatric intensive care units. Am J Infect Control 2001;29:152–7. [CrossRef]
6. Haas J, Larson E, Ross B, See B, Saiman L. Epidemiology and diagnosis of hospital-acquired conjunctivitis among neonatal intensive care unit patients. Pediatr Infect Dis J 2005;24:586–9.
7. Raskind CH, Sabo BE, Callan DA, Farrel PA, Dembry LM, Gallagher PG. Conjunctival colonization of infants hospitalized in a neonatal intensive care unit: a longitudinal analysis. Infect Control Hosp Epidemiol 2004;25:216–20. [CrossRef]
8. Fierson WM; American Academy of Pediatrics Section on Ophthalmology; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus; American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2013;131:189–95. [CrossRef]
9. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309–32. [CrossRef]
10. Simon JW. Povidone-iodine prophylaxis of ophthalmia neonatorum. Br J Ophthalmol 2003;87:1437. [CrossRef]
11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 16th informational supplement M100-S16. Wayne, PA: CLSI; 2006.
12. Brito DV, Brito CS, Resende DS, Moreira do Ó J, Abdallah VO, Gontijo Filho PP. Nosocomial infections in a Brazilian neonatal intensive care unit: a 4-year surveillance study. Rev Soc Bras Med Trop 2010;43:633–7. [CrossRef]
13. Faden H, Wynn RJ, Campagna L, Ryan RM. Outbreak of adenovirus type 30 in a neonatal intensive care unit. J Pediatr 2005;146:523–7. [CrossRef]
14. Prentice MJ, Hutchinson GR, Taylor-Robinsin D. A microbiological study of neonatal conjunctivae and conjunctivitis. Br J Ophthalmol 1977;61:601–7. [CrossRef]
15. O'Keefe M, Nolan L, Lanigan B, Murphy J. Pseudomonas aeruginosa endophthalmitis in a preterm infant. J AAPOS 2005;9:288–9. [CrossRef]
16. Chen CJ, Starr CE. Epidemiology of gram-negative conjunctivitis in neonatal intensive care unit patients. Am J Ophthalmol 2008;145:966–70. [CrossRef]
17. Lichtenstein SJ, Rinehart M; Levofloxacin Bacterial Conjunctivitis Study Group. Efficacy and safety of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in pediatric patients. J AAPOS 2003;7:317–24. [CrossRef]
18. Leibowitz HM. Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis. Am J Ophthalmol 1991;112:29S–33S.